| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |